Cinromide
Drug profile
Also known as: vumide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Cinromide is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including SLC6A19.
- Molecular targets: SLC6A19 (1 listed in DrugCentral).
- Molecular formula: C11H12BrNO; molecular weight 254.13 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sodium-dependent neutral amino acid transporter B(0)AT1 | SLC6A19 | inhibitor | IC50 6.40 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Cinromide is on its molecule page.
| Molecular formula | C11H12BrNO |
|---|---|
| Molecular weight | 254.13 g/mol |
| CAS number | — |
| InChIKey | LDCXGZCEMNMWIL-VOTSOKGWSA-N |
| PubChem CID | 688145 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Cinromide work?
Its molecular targets in DrugCentral include SLC6A19 (inhibitor).
What is the chemical formula of Cinromide?
Cinromide has the molecular formula C11H12BrNO and a molecular weight of 254.13 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3102 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL93233 — compound record and bioactivity
- PubChem CID 688145 — chemical identifiers
- FDA UNII M197KE7A5N — substance identity
- UniProt Q695T7 (SLC6A19) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.